Visit the Bruker Daltonics web site
Click on the advert above to visit the company web site

Product category: Laboratory and scientific databases
News Release from: Waters | Subject: MarkerLynx DB
Edited by the Laboratorytalk Editorial Team on 04 July 2005

Accelerate metabonomics biomarker
discovery

Request your FREE weekly copy of the Laboratorytalk email newsletter. News about Laboratory and scientific databases and more every issue. Click here for details.

Database application allows scientists to process LC/MS and GC/MS data and perform 3D peak integration, noise elimination, metabolite removal, peak alignment and multivariate statistical analysis

LC/MS and GC/MS-driven biomarker discovery holds a key to understanding mechanisms of toxicity for the development of new medicines, and the optimisation of industrial and agrochemical processes In pursuit of metabonomics biomarker knowledge, these information-rich techniques require sophisticated software tools to process and interpret large amounts of data

In response to this challenge, Waters has announced the introduction of the dedicated MarkerLynx DB (database) application manager for MassLynx 4.1 software for multivariate statistical analysis and database searching.

Building upon the success of the MarkerLynx application manager introduced in 2003, MarkerLynx DB features improved peak detection, enhanced statistical tools, and new dynamic database searching and storage capabilities for the identification of important biomarkers, launched directly from the statistical results browser.

According to Brian Smith, senior director, pharmaceutical business development: "With the introduction of MarkerLynx DB, Waters sets a new standard in metabonomics and biomarker data management.

"We have listened to the needs of our customers and collaborators, and have delivered the best in data analysis, interpretation and archival tools for a truly comprehensive solution".

Metabonomics helps predict the efficacy and toxicity of new drug compounds and has the potential to impact characterisation and efficiency of industrial operations, says Waters.

To achieve success in metabonomics, scientists must develop reliable and efficient assays to rapidly detect as many analytes as possible with a high degree of sensitivity and resolution.

The next crucial step is to process and interpret large amounts of information-rich data to derive meaningful results.

With the MarkerLynx DB application manager, the company says scientists can seamlessly process LC/MS and GC/MS data and perform such tasks as three-dimensional peak integration, noise elimination, metabolite removal, peak alignment and multivariate statistical analysis.

Collaborating with leaders in metabolite profiling, Waters enhanced the core capabilities of the application manager, allowing researchers to more easily process their data, visualise statistical results, interact with raw data, and dynamically search and store metabolic information in a relational database.

MarkerLynx DB is an essential component of Waters's total system solution for metabonomics.

Along with the company's Acquity LC system, high-resolution exact mass Premier family of mass spectrometers, and MassLynx 4.1 software, scientists have a cohesive solution for every metabonomics application, says the company.

Waters: contact details and other news
Email this article to a colleague
Register for the free Laboratorytalk email newsletter
Laboratorytalk Home Page

Search the Pro-Talk network of sites

Visit the Bruker Daltonics web site